Adient Awarded Direct to Phase 2 SBIR; $1.5M Grant

We are pleased to announce that Adient Medical has been awarded a direct to Phase 2 Small Business Innovation Research (SBIR) grant for $1.5M over a two year period by the National Heart, Lung, and Blood Institute for its Resorbable Inferior Vena Cava Filter.  Mitch Eggers, CEO and founder of Adient, commented, “We are honored to have received such a great review from the national scoring board and to be placed in the direct Phase 2 track.  The money from the grant allows us to continue to push through the necessary steps to obtain FDA clearance for our filter.”